Curtin PARP (Passionate About Realising your Potential) Fund
A Professor of Experimental Cancer Therapeutics at Newcastle University, involved in the creation of Rubraca®, a new cancer drug that has been approved for use on the NHS, has donated her share of proceeds to the Community Foundation.
The Curtin PARP (Passionate About Realising your Potential) Fund at the Community Foundation was established with a generous gift of nearly £865,000 by Professor Nicola Curtin and aims to help individuals realise their potential in life.
The Curtin PARP Fund at the Community Foundation is now open for applications in 2019, with a deadline of Monday 2 December and will reopen in mid-January for the 2020 round, receiving applications at any point throughout the year.
The Fund will support a range of activities to help people to develop the skills, talents and confidence to overcome barriers to employment or education. Priority will be given to carers, black and minority ethnic people, disabled people, homeless people and people who are experiencing disadvantage that prevents them from realising their potential.
The Fund is named after the drug, which is classed as a PARP inhibitor, and works by exploiting a defect in the cancer cell’s ability to repair normal wear and tear to its DNA.
Professor Nicola Curtin says:
“I know first-hand that people are capable of amazing things, but society sometimes doesn’t always allow people to reach their full potential. So, through the Curtin PARP Fund at the Community Foundation I want to leave a lasting legacy that will change lives for the better.”
Read the full article on the Community Foundation's website.
For more information about applying to the Curtin PARP Fund at the Community Foundation visit the website.